Cardiovascular Research Foundation
88% goes to programs $1 to raise $100 Strong reserves Growing revenue
Cardiovascular Research Foundation is a 501(c)(3) organization based in New York, New York, registered in 1992, with $68,904,326 in FY2024 revenue. CharityIndex grades it A, and it directs about 88% of spending to programs.
1700 Broadway 9th Floor, New York, NY, 10019 EIN 52-1752653 Since 1992
Revenue (FY2024)
$68.9M
▼ 12.0% vs prior year
Medical Research median: $217K
Expenses (FY2024)
$66.7M
Net assets
$50.2M
Employees
213
CharityIndex rating
One independent A+ to F grade from four published criteria, each scored separately from IRS filings and combined by weight.
A
AProgram efficiency40% of the rating88% to programs · $1 to raise $100
Measures how much of every dollar spent actually reaches programs, plus what it costs to raise $100 of donations. The worse of the two measures sets the letter (85%+ to programs is an A; under $15 to raise $100 is an A), averaged over the three most recent filings. For Cardiovascular Research Foundation: 88% to programs · $1 to raise $100 earns a A on this criterion. See the exact thresholds →
AFinancial health25% of the rating9 mo reserves · +3% margin
Measures whether the organization is built to last: how many months its reserves would cover expenses (3+ months earns an A-range score, but hoarding 5+ years of budget is capped) and whether it runs a surplus or a deficit. For Cardiovascular Research Foundation: 9 mo reserves · +3% margin earns a A on this criterion. See the exact thresholds →
A+Governance25% of the rating6 of 6 checks met
Checks how the organization is run, from its own Form 990: an independent board majority, a board of five or more, conflict-of-interest, whistleblower and document-retention policies, and independently audited financials. The share of disclosed checks that pass sets the letter. For Cardiovascular Research Foundation: 6 of 6 checks met earns a A+ on this criterion. See the exact thresholds →
A+Transparency10% of the rating5 of 5 disclosure signals
Counts five disclosure signals: a recent filing, a mission statement, program descriptions, a listed website, and the full expense breakdown. More disclosure, better letter. For Cardiovascular Research Foundation: 5 of 5 disclosure signals earns a A+ on this criterion. See the exact thresholds →
Show this grade on your website
A live seal — it updates automatically when the grade changes and links donors to this verified profile.
Mission
Cardiovascular research foundation is an independent, academically focused organization dedicated to improving the survival and quality of life for people with cardiovascular disease through research and education. the organization has played a major role in realizing dramatic improvements in the lives of countless numbers of patients by establishing the safe use of new technologies and therapies in the subspecialty of interventional cardiology and endovascular medicine.
What they do
Skirball center for innovation - a state of the art innovation center, the crf skirball center for innovation is dedicated to the investigation and validation of novel concepts, treatments, and devices. our preeminent team of pioneering researchers and thought leaders continually break new ground as they guide early ideas and inventions through comprehensive preclinical research programs to introduce practical therapies into clinical medicine.
Tct 2024 (transcatheter cardiovascular therapeutics) meeting - the cardiovascular research foundation (crf) stands at the forefront of education in cardiovascular medicine. this focus reflects the crf faculty's commitment to sharing and disseminating the latest clinical research information to the broadest audience at the earliest possible date. the fundamental goal of crf's education program is to enable the global physician community to apply important new knowledge to actual patient care. crf's principal annual educational event, transcatheter cardiovascular therapeutics (tct) meeting, is the world's largest educational meeting dedicated to the field of interventional vascular therapy. this is the showcase educational event in the cardiovascular field and is used to educate and exchange study findings and to improve treatment of patients who have cardiovascular disease.
Other - includes web services, other small meetings, and support functions to each of the divisions above.
Contact & location
- Address
- 1700 Broadway 9th Floor, New York, NY, 10019
- City
- New York
- State
- New York
- Category
- Medical Research
- Subcategory
- Birth Defects Research
- Phone
- …
- Website
- …
Financial trends
Revenue grew from $47.2M (FY2013) to $68.9M (FY2024) across 12 reported years.
Financial snapshot
Financial health & position (FY2024)
Liabilities $37.2MNet assets $50.2M
Operating margin
3.3%
Revenue exceeded expenses in the latest fiscal year.
Total assets
$87.5M
Total liabilities
$37.2M
Net assets
$50.2M
Salaries & benefits
$26.8M
40% of expenses
Board members
11
10 independent
Financials by year
| Fiscal year | Revenue | Expenses | Net assets | Total assets | Form |
|---|---|---|---|---|---|
| 2024 | $68,904,326▼12.0% | $66,655,898▲2.6% | $50,242,608▲8.2% | $87,491,417▼4.9% | 990 |
| 2023 | $78,271,229▲27.6% | $64,971,760▲13.4% | $46,425,714▲42.0% | $91,969,884▲20.9% | 990 |
| 2022 | $61,324,834▲17.3% | $57,291,678▲21.0% | $32,695,461▲4.9% | $76,093,334▲32.5% | 990 |
| 2021 | $52,277,749▲39.4% | $47,332,137▲14.2% | $31,155,641▲22.9% | $57,426,030▲2.6% | 990 |
| 2020 | $37,490,664▼42.9% | $41,452,402▼25.9% | $25,348,323▼12.7% | $55,991,119▼7.8% | 990 |
| 2019 | $65,620,319▲8.0% | $55,971,546▲3.6% | $29,039,948▲58.1% | $60,748,866▲27.3% | 990 |
| 2018 | $60,750,509▲8.0% | $54,012,608▼0.8% | $18,371,369▲49.5% | $47,712,737▲13.9% | 990 |
| 2017 | $56,259,563▲2.2% | $54,447,845▲1.6% | $12,285,559▲24.3% | $41,874,156▲8.2% | 990 |
| 2016 | $55,036,963▲9.5% | $53,592,613▲5.6% | $9,884,042▲16.6% | $38,713,115▲14.1% | 990 |
| 2015 | $50,260,197▲3.2% | $50,750,916▲4.4% | $8,474,007▼4.9% | $33,936,359▲3.8% | 990 |
| 2014 | $48,702,682▲3.2% | $48,596,443▲4.0% | $8,915,289▼2.4% | $32,702,183▼5.1% | 990 |
| 2013 | $47,210,161 | $46,723,957▲12.7% | $9,137,350▲9.0% | $34,457,308▲1.0% | 990 |
| 2012 | — | $41,451,412▲2.6% | $8,381,563▲47.3% | $34,119,818▲1.0% | 990 |
| 2011 | — | $40,392,407▼4.4% | $5,690,105▲94.1% | $33,795,070▲16.3% | 990 |
| 2010 | — | $42,248,078 | $2,931,858 | $29,055,505 | 990 |
Original Form 990 PDFs (the Form column) are served by ProPublica Nonprofit Explorer, as filed with the IRS. Create a free account to download the CSV report.
Leadership & compensation (FY2024)
Highest-paid: Juan F Granada Md — $933,460 (1.40% of total expenses)
| Name | Title | Hours/week | Compensation |
|---|---|---|---|
| Juan F Granada Md | Ceo & Director | 37.5 | $933,460 |
| David Cohen | Director of Clinical & Out | 37.5 | $700,158 |
| Donald L Abrams | Chief Legal Officer | 37.5 | $482,912 |
| Eileen Morales | Cfo | 37.5 | $474,963 |
| Alexandra Popma | Director | 37.5 | $461,897 |
| Tricia Rawh | Executive Director, Ced | 37.5 | $431,480 |
| Grzegorz Kaluza | Director Research | 37.5 | $325,318 |
| Daniel Burkoff | Director of Heart Failure | 37.5 | $315,075 |
| Colette Y Gardner | Director | 2 | — |
| Eric B Woldenberg | Chairman | 2 | — |
| Frank Litvack Md | Director | 2 | — |
| Jeffrey W Moses Md | Director | 2 | — |
| Joseph G Beck | Director | 2 | — |
| Karen G Krasney | Director | 2 | — |
| Martin B Leon Md | Director | 2 | — |
| Marvin L Woodall | Director | 2 | — |
| Teresa Leste | Director | 2 | — |
| William A Himmelsbach | Director | 2 | — |
Top vendors & contractors (FY2024)
| Contractor | Services | Paid |
|---|---|---|
| Gary S Mintz Md LLC | Management Consulting | $310,000 |
| Lissom Corp | Management Consulting | $201,093 |
| Fixed Gear Designs | Management Consulting | $179,393 |
| Very Fine Work | Management Consulting | $155,870 |
| Mattthew Schwartz Design Studio LLC | Management Consulting | $140,000 |
Grants received · $166K total
9 grants to Cardiovascular Research Foundation totaling $166K, reported by foundations on their Schedule I filings.
| Grantmaker | Purpose | Year | Amount |
|---|---|---|---|
| Fidelity Investments Charitable Gift Fund | For grant recipient's exempt purposes | 2023 | $33,600 |
| Trustees of Columbia University | Program services | 2023 | $15,000 |
| Donor Advised Charitable Giving | Health | 2019 | $10,000 |
| The New York and Presbyterian Hospital | Support | 2018 | $15,800 |
| The New York and Presbyterian Hospital | Support | 2017 | $12,800 |
| The New York and Presbyterian Hospital | Support | 2016 | $47,800 |
| Trustees of Columbia University | Program services | 2016 | $15,000 |
| Donor Advised Charitable Giving | Health & human services | 2015 | $10,000 |
| Trustees of Columbia University | Program services | 2015 | $6,000 |
Grants made · $1.0M in FY2024
1 grant totaling $1.0M in FY2024. All grants made by Cardiovascular Research Foundation →
| Recipient | Purpose | Amount |
|---|---|---|
| Trustees of Columbia University | Clinical research in the field of cardiovascular medicine | $1,000,000 |
Similar organizations in Medical Research
Medical Research
Global Alliance For Tb Drug Development Inc
New York, NY
$63.7M
Aannual revenue
- Medical Research
Licr Fund Inc
New York, NY
$79.0M
Aannual revenue
Medical Research
Parkinsons Foundation Inc
New York, NY
$84.2M
Aannual revenue
- Medical Research
International Brain Research Organization
New York, NY
$37.2M
C+annual revenue
Medical Research
The International Academy of Hope
New York, NY
$32.6M
Bannual revenue
Medical Research
The Foundation For Aids Research
New York, NY
$24.8M
C+annual revenue
Medical Research
Cancer Research Institute Inc
New York, NY
$24.0M
Dannual revenue
Medical Research
New York Stem Cell Foundation Inc
New York, NY
$23.1M
Dannual revenue
Medical Research
Childrens Tumor Foundation
New York, NY
$19.7M
Bannual revenue
- Medical Research
Winifred Masterson Burke Medical Research
White Plains, NY
$19.7M
Dannual revenue
Compare Cardiovascular Research Foundation
Frequently asked questions
- Is Cardiovascular Research Foundation a legitimate nonprofit?
- Yes. Cardiovascular Research Foundation is a 501(c)(3) organization registered with the U.S. Internal Revenue Service under EIN 52-1752653, based in New York, New York. Donations are tax-deductible.
- What is Cardiovascular Research Foundation's EIN?
- Cardiovascular Research Foundation's Employer Identification Number (EIN) is 52-1752653.
- How much revenue does Cardiovascular Research Foundation report?
- Cardiovascular Research Foundation reported $68,904,326 in total revenue on its fiscal year 2024 IRS Form 990 filing.
- How much of Cardiovascular Research Foundation's spending goes to programs?
- Cardiovascular Research Foundation spends about 88% of its total expenses on programs, based on its latest IRS Form 990.
- What financial grade does Cardiovascular Research Foundation have?
- CharityIndex grades Cardiovascular Research Foundation A, based on program efficiency and fundraising cost.
- How much does Cardiovascular Research Foundation's highest-paid employee make?
- The highest reported compensation on Cardiovascular Research Foundation's latest Form 990 is $933,460, paid to Juan F Granada Md (Ceo & Director).
More nonprofits in New York
Explore more
Data for Cardiovascular Research Foundation (EIN 52-1752653) comes from the IRS Business Master File and e-filed Form 990 returns, via CharityIndex. Figures reflect what the organization reported to the IRS for each fiscal year.